MENU
+Compare
MREO
Stock ticker: NASDAQ
AS OF
Apr 1 closing price
Price
$2.17
Change
-$0.08 (-3.56%)
Capitalization
358.55M

MREO Mereo BioPharma Group plc Forecast, Technical & Fundamental Analysis

Mereo BioPharma Group PLC is a United Kingdom (U... Show more

MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MREO with price predictions
Mar 31, 2025

MREO in upward trend: price expected to rise as it breaks its lower Bollinger Band on March 25, 2025

MREO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 38 cases where MREO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MREO's RSI Indicator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MREO advanced for three days, in of 246 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MREO as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MREO turned negative on March 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MREO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MREO entered a downward trend on March 31, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.659) is normal, around the industry mean (13.677). P/E Ratio (0.000) is within average values for comparable stocks, (64.969). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.870). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (344.828) is also within normal values, averaging (255.565).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MREO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MREO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MREO is expected to report earnings to fall 240.00% to 1 cents per share on May 14

Mereo BioPharma Group plc MREO Stock Earnings Reports
Q1'25
Est.
$0.01
Q4'24
Est.
$-0.01
Q3'24
Est.
$-0.02
Q2'24
Missed
by $0.01
Q4'23
Est.
$-0.02
The last earnings report on March 26 showed earnings per share of 0 cents, meeting the estimate of 0 cents. With 1.45M shares outstanding, the current market capitalization sits at 358.55M.
A.I. Advisor
published General Information

General Information

a company, which engages in therapeutics that aim to improve outcomes for patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic obstructive pulmonary disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Cavendish Place
Phone
+44 3330237300
Employees
33
Web
https://www.mereobiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EZTGX48.03N/A
N/A
Eaton Vance Tx-Mgd Growth 1.2 C
TIIRX24.95N/A
N/A
Nuveen Core Equity A
JFCIX34.59N/A
N/A
JHancock Fundamental All Cap Core I
RDCCX7.98N/A
N/A
Columbia Disciplined Value C
EFCIX19.36N/A
N/A
Emerald Insights Institutional

MREO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been loosely correlated with TERN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
-2.17%
TERN - MREO
40%
Loosely correlated
-5.48%
VKTX - MREO
38%
Loosely correlated
-5.85%
TRDA - MREO
38%
Loosely correlated
-5.44%
MDGL - MREO
37%
Loosely correlated
+1.02%
CRNX - MREO
36%
Loosely correlated
-3.43%
More